EMEA (Europe, Middle East and Africa) Passive Transdermal Drug Delivery Market Report 2018

March 2018 | 118 pages | ID: E0944CCEADCEN
QYResearch

Abstracts

In this report, the EMEA Passive Transdermal Drug Delivery market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Passive Transdermal Drug Delivery for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Passive Transdermal Drug Delivery market competition by top manufacturers/players, with Passive Transdermal Drug Delivery sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• 3M
• Actavis, Inc.
• Bayer AG
• Boehringer Ingelheim GmbH
• Corium International, Inc.
• Echo Therapeutics, Inc.
• GlaxoSmithKline plc
• Johnson & Johnson (Janssen Pharmaceuticals Inc.)
• Mylan N.V.
• Novartis AG
• Noven Pharmaceuticals, Inc.
• Transdermal Corp.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Microfluidics
• Smart Pill Technology (SPT)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Clinic
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Passive Transdermal Drug Delivery Market Report 2018

1 PASSIVE TRANSDERMAL DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Passive Transdermal Drug Delivery
1.2 Classification of Passive Transdermal Drug Delivery
  1.2.1 EMEA Passive Transdermal Drug Delivery Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Passive Transdermal Drug Delivery Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Microfluidics
  1.2.4 Smart Pill Technology (SPT)
1.3 EMEA Passive Transdermal Drug Delivery Market by Application/End Users
  1.3.1 EMEA Passive Transdermal Drug Delivery Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 EMEA Passive Transdermal Drug Delivery Market by Region
  1.4.1 EMEA Passive Transdermal Drug Delivery Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Passive Transdermal Drug Delivery (2013-2025)
  1.5.1 EMEA Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2025)

2 EMEA PASSIVE TRANSDERMAL DRUG DELIVERY COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Passive Transdermal Drug Delivery Market Competition by Players/Manufacturers
  2.1.1 EMEA Passive Transdermal Drug Delivery Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Passive Transdermal Drug Delivery Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Passive Transdermal Drug Delivery Sale Price by Players (2013-2018)
2.2 EMEA Passive Transdermal Drug Delivery (Volume and Value) by Type/Product Category
  2.2.1 EMEA Passive Transdermal Drug Delivery Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Passive Transdermal Drug Delivery Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Passive Transdermal Drug Delivery Sale Price by Type (2013-2018)
2.3 EMEA Passive Transdermal Drug Delivery (Volume) by Application
2.4 EMEA Passive Transdermal Drug Delivery (Volume and Value) by Region
  2.4.1 EMEA Passive Transdermal Drug Delivery Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Passive Transdermal Drug Delivery Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Passive Transdermal Drug Delivery Sales Price by Region (2013-2018)

3 EUROPE PASSIVE TRANSDERMAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Passive Transdermal Drug Delivery Sales and Value (2013-2018)
  3.1.1 Europe Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2018)
3.2 Europe Passive Transdermal Drug Delivery Sales and Market Share by Type
3.3 Europe Passive Transdermal Drug Delivery Sales and Market Share by Application
3.4 Europe Passive Transdermal Drug Delivery Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Passive Transdermal Drug Delivery Sales Volume by Countries (2013-2018)
  3.4.2 Europe Passive Transdermal Drug Delivery Revenue by Countries (2013-2018)
  3.4.3 Germany Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  3.4.4 France Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  3.4.5 UK Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  3.4.6 Russia Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  3.4.7 Italy Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)

4 MIDDLE EAST PASSIVE TRANSDERMAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Passive Transdermal Drug Delivery Sales and Value (2013-2018)
  4.1.1 Middle East Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2018)
4.2 Middle East Passive Transdermal Drug Delivery Sales and Market Share by Type
4.3 Middle East Passive Transdermal Drug Delivery Sales and Market Share by Application
4.4 Middle East Passive Transdermal Drug Delivery Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Passive Transdermal Drug Delivery Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Passive Transdermal Drug Delivery Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  4.4.4 Israel Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  4.4.5 UAE Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  4.4.6 Iran Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)

5 AFRICA PASSIVE TRANSDERMAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Passive Transdermal Drug Delivery Sales and Value (2013-2018)
  5.1.1 Africa Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2018)
5.2 Africa Passive Transdermal Drug Delivery Sales and Market Share by Type
5.3 Africa Passive Transdermal Drug Delivery Sales and Market Share by Application
5.4 Africa Passive Transdermal Drug Delivery Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Passive Transdermal Drug Delivery Sales Volume by Countries (2013-2018)
  5.4.2 Africa Passive Transdermal Drug Delivery Revenue by Countries (2013-2018)
  5.4.3 South Africa Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Passive Transdermal Drug Delivery Sales and Growth Rate (2013-2018)

6 EMEA PASSIVE TRANSDERMAL DRUG DELIVERY MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 3M
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Passive Transdermal Drug Delivery Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Actavis, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Passive Transdermal Drug Delivery Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Bayer AG
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Passive Transdermal Drug Delivery Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim GmbH
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Passive Transdermal Drug Delivery Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Corium International, Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Passive Transdermal Drug Delivery Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Echo Therapeutics, Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Passive Transdermal Drug Delivery Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 GlaxoSmithKline plc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Passive Transdermal Drug Delivery Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Passive Transdermal Drug Delivery Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Mylan N.V.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Passive Transdermal Drug Delivery Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Novartis AG
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Passive Transdermal Drug Delivery Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Noven Pharmaceuticals, Inc.
6.12 Transdermal Corp.

7 PASSIVE TRANSDERMAL DRUG DELIVERY MANUFACTURING COST ANALYSIS

7.1 Passive Transdermal Drug Delivery Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Passive Transdermal Drug Delivery Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Passive Transdermal Drug Delivery Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PASSIVE TRANSDERMAL DRUG DELIVERY MARKET FORECAST (2018-2025)

11.1 EMEA Passive Transdermal Drug Delivery Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Passive Transdermal Drug Delivery Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Passive Transdermal Drug Delivery Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Passive Transdermal Drug Delivery Price and Trend Forecast (2018-2025)
11.2 EMEA Passive Transdermal Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Passive Transdermal Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Passive Transdermal Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Passive Transdermal Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Passive Transdermal Drug Delivery Sales Forecast by Type (2018-2025)
11.7 EMEA Passive Transdermal Drug Delivery Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Passive Transdermal Drug Delivery
Figure EMEA Passive Transdermal Drug Delivery Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Passive Transdermal Drug Delivery Sales Volume Market Share by Type (Product Category) in 2017
Figure Microfluidics Product Picture
Figure Smart Pill Technology (SPT) Product Picture
Figure EMEA Passive Transdermal Drug Delivery Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Passive Transdermal Drug Delivery by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Passive Transdermal Drug Delivery Market Size (Million USD) by Region (2013-2025)
Figure Europe Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Passive Transdermal Drug Delivery Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Passive Transdermal Drug Delivery Revenue (Million USD) Status and Forecast by Countries
Figure Africa Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Passive Transdermal Drug Delivery Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2013-2025)
Figure EMEA Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Passive Transdermal Drug Delivery Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Passive Transdermal Drug Delivery Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Passive Transdermal Drug Delivery Sales Share by Players (2013-2018)
Figure 2017 Passive Transdermal Drug Delivery Sales Share by Players
Figure 2017 Passive Transdermal Drug Delivery Sales Share by Players
Figure EMEA Passive Transdermal Drug Delivery Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Passive Transdermal Drug Delivery Revenue (Million USD) by Players (2013-2018)
Table EMEA Passive Transdermal Drug Delivery Revenue Share by Players (2013-2018)
Table 2017 EMEA Passive Transdermal Drug Delivery Revenue Share by Players
Table 2017 EMEA Passive Transdermal Drug Delivery Revenue Share by Players
Table EMEA Passive Transdermal Drug Delivery Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Passive Transdermal Drug Delivery Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Passive Transdermal Drug Delivery Sales Share by Type (2013-2018)
Figure Sales Market Share of Passive Transdermal Drug Delivery by Type (2013-2018)
Figure EMEA Passive Transdermal Drug Delivery Sales Market Share by Type (2013-2018)
Table EMEA Passive Transdermal Drug Delivery Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Passive Transdermal Drug Delivery Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Passive Transdermal Drug Delivery by Type in 2017
Table EMEA Passive Transdermal Drug Delivery Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Passive Transdermal Drug Delivery Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Passive Transdermal Drug Delivery Sales Share by Application (2013-2018)
Figure Sales Market Share of Passive Transdermal Drug Delivery by Application (2013-2018)
Figure EMEA Passive Transdermal Drug Delivery Sales Market Share by Application in 2017
Table EMEA Passive Transdermal Drug Delivery Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Passive Transdermal Drug Delivery Sales Share by Region (2013-2018)
Figure Sales Market Share of Passive Transdermal Drug Delivery by Region (2013-2018)
Figure EMEA Passive Transdermal Drug Delivery Sales Market Share in 2017
Table EMEA Passive Transdermal Drug Delivery Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Passive Transdermal Drug Delivery Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Passive Transdermal Drug Delivery by Region (2013-2018)
Figure EMEA Passive Transdermal Drug Delivery Revenue Market Share Regions in 2017
Table EMEA Passive Transdermal Drug Delivery Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Revenue and Growth Rate (2013-2018)
Table Europe Passive Transdermal Drug Delivery Sales (K Units) by Type (2013-2018)
Table Europe Passive Transdermal Drug Delivery Market Share by Type (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Market Share by Type in 2017
Table Europe Passive Transdermal Drug Delivery Sales (K Units) by Application (2013-2018)
Table Europe Passive Transdermal Drug Delivery Market Share by Application (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Market Share by Application in 2017
Table Europe Passive Transdermal Drug Delivery Sales (K Units) by Countries (2013-2018)
Table Europe Passive Transdermal Drug Delivery Sales Market Share by Countries (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Sales Market Share by Countries (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Sales Market Share by Countries in 2017
Table Europe Passive Transdermal Drug Delivery Revenue (Million USD) by Countries (2013-2018)
Table Europe Passive Transdermal Drug Delivery Revenue Market Share by Countries (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Revenue Market Share by Countries (2013-2018)
Figure Europe Passive Transdermal Drug Delivery Revenue Market Share by Countries in 2017
Figure Germany Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure France Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure UK Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Passive Transdermal Drug Delivery Sales (K Units) by Type (2013-2018)
Table Middle East Passive Transdermal Drug Delivery Market Share by Type (2013-2018)
Figure Middle East Passive Transdermal Drug Delivery Market Share by Type (2013-2018)
Table Middle East Passive Transdermal Drug Delivery Sales (K Units) by Applications (2013-2018)
Table Middle East Passive Transdermal Drug Delivery Market Share by Applications (2013-2018)
Figure Middle East Passive Transdermal Drug Delivery Sales Market Share by Application in 2017
Table Middle East Passive Transdermal Drug Delivery Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Passive Transdermal Drug Delivery Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Passive Transdermal Drug Delivery Sales Volume Market Share by Countries in 2017
Table Middle East Passive Transdermal Drug Delivery Revenue (Million USD) by Countries (2013-2018)
Table Middle East Passive Transdermal Drug Delivery Revenue Market Share by Countries (2013-2018)
Figure Middle East Passive Transdermal Drug Delivery Revenue Market Share by Countries (2013-2018)
Figure Middle East Passive Transdermal Drug Delivery Revenue Market Share by Countries in 2017
Figure Saudi Arabia Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Passive Transdermal Drug Delivery Sales (K Units) by Type (2013-2018)
Table Africa Passive Transdermal Drug Delivery Sales Market Share by Type (2013-2018)
Figure Africa Passive Transdermal Drug Delivery Sales Market Share by Type (2013-2018)
Figure Africa Passive Transdermal Drug Delivery Sales Market Share by Type in 2017
Table Africa Passive Transdermal Drug Delivery Sales (K Units) by Application (2013-2018)
Table Africa Passive Transdermal Drug Delivery Sales Market Share by Application (2013-2018)
Figure Africa Passive Transdermal Drug Delivery Sales Market Share by Application (2013-2018)
Table Africa Passive Transdermal Drug Delivery Sales Volume (K Units) by Countries (2013-2018)
Table Africa Passive Transdermal Drug Delivery Sales Market Share by Countries (2013-2018)
Figure Africa Passive Transdermal Drug Delivery Sales Market Share by Countries (2013-2018)
Figure Africa Passive Transdermal Drug Delivery Sales Market Share by Countries in 2017
Table Africa Passive Transdermal Drug Delivery Revenue (Million USD) by Countries (2013-2018)
Table Africa Passive Transdermal Drug Delivery Revenue Market Share by Countries (2013-2018)
Figure Africa Passive Transdermal Drug Delivery Revenue Market Share by Countries (2013-2018)
Figure Africa Passive Transdermal Drug Delivery Revenue Market Share by Countries in 2017
Figure South Africa Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Table 3M Passive Transdermal Drug Delivery Basic Information List
Table 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure 3M Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure 3M Passive Transdermal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure 3M Passive Transdermal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Actavis, Inc. Passive Transdermal Drug Delivery Basic Information List
Table Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Bayer AG Passive Transdermal Drug Delivery Basic Information List
Table Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer AG Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Bayer AG Passive Transdermal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Bayer AG Passive Transdermal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Basic Information List
Table Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Corium International, Inc. Passive Transdermal Drug Delivery Basic Information List
Table Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Basic Information List
Table Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Basic Information List
Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Basic Information List
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Mylan N.V. Passive Transdermal Drug Delivery Basic Information List
Table Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Mylan N.V. Passive Transdermal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Mylan N.V. Passive Transdermal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Novartis AG Passive Transdermal Drug Delivery Basic Information List
Table Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Novartis AG Passive Transdermal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Novartis AG Passive Transdermal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Basic Information List
Table Transdermal Corp. Passive Transdermal Drug Delivery Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Passive Transdermal Drug Delivery
Figure Manufacturing Process Analysis of Passive Transdermal Drug Delivery
Figure Passive Transdermal Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Passive Transdermal Drug Delivery Major Manufacturers in 2017
Table Major Buyers of Passive Transdermal Drug Delivery
Table Distributors/Traders List
Figure EMEA Passive Transdermal Drug Delivery Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Passive Transdermal Drug Delivery Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Passive Transdermal Drug Delivery Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Passive Transdermal Drug Delivery Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Passive Transdermal Drug Delivery Sales Market Share Forecast by Region (2018-2025)
Table EMEA Passive Transdermal Drug Delivery Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Passive Transdermal Drug Delivery Revenue Market Share Forecast by Region (2018-2025)
Table Europe Passive Transdermal Drug Delivery Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Passive Transdermal Drug Delivery Sales Market Share Forecast by Countries (2018-2025)
Table Europe Passive Transdermal Drug Delivery Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Passive Transdermal Drug Delivery Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Passive Transdermal Drug Delivery Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Passive Transdermal Drug Delivery Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Passive Transdermal Drug Delivery Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Passive Transdermal Drug Delivery Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Passive Transdermal Drug Delivery Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Passive Transdermal Drug Delivery Sales Market Share Forecast by Countries (2018-2025)
Table Africa Passive Transdermal Drug Delivery Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Passive Transdermal Drug Delivery Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Passive Transdermal Drug Delivery Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Passive Transdermal Drug Delivery Sales Market Share Forecast by Type (2018-2025)
Table EMEA Passive Transdermal Drug Delivery Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Passive Transdermal Drug Delivery Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources